DK1259606T3 - Compositions suitable for regulating parkin activity - Google Patents

Compositions suitable for regulating parkin activity

Info

Publication number
DK1259606T3
DK1259606T3 DK01907820.3T DK01907820T DK1259606T3 DK 1259606 T3 DK1259606 T3 DK 1259606T3 DK 01907820 T DK01907820 T DK 01907820T DK 1259606 T3 DK1259606 T3 DK 1259606T3
Authority
DK
Denmark
Prior art keywords
compositions suitable
parkin activity
regulating
regulating parkin
activity
Prior art date
Application number
DK01907820.3T
Other languages
Danish (da)
Inventor
Hana Koutnikova
Laurent Pradier
Catherine Prades
Isabelle Arnould-Reguigne
Alexis Brice
Alain Fournier
Olga Corti
Marie-Francoise Rosier-Montus
Original Assignee
Aventis Pharma Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Inst Nat Sante Rech Med filed Critical Aventis Pharma Sa
Priority claimed from PCT/FR2001/000461 external-priority patent/WO2001060857A2/en
Application granted granted Critical
Publication of DK1259606T3 publication Critical patent/DK1259606T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01907820.3T 2000-02-17 2001-02-15 Compositions suitable for regulating parkin activity DK1259606T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001980A FR2805266B1 (en) 2000-02-17 2000-02-17 COMPOSITIONS FOR USE IN CONTROLLING PARKIN ACTIVITY
US19848900P 2000-04-18 2000-04-18
PCT/FR2001/000461 WO2001060857A2 (en) 2000-02-17 2001-02-15 Compositions useful for regulating parkin gene activity

Publications (1)

Publication Number Publication Date
DK1259606T3 true DK1259606T3 (en) 2010-08-23

Family

ID=8847103

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01907820.3T DK1259606T3 (en) 2000-02-17 2001-02-15 Compositions suitable for regulating parkin activity

Country Status (6)

Country Link
JP (1) JP4861590B2 (en)
DK (1) DK1259606T3 (en)
ES (1) ES2345318T3 (en)
FR (1) FR2805266B1 (en)
PT (1) PT1259606E (en)
ZA (1) ZA200206550B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004500813A (en) * 1999-12-21 2004-01-15 インサイト・ゲノミックス・インコーポレイテッド Vesicle transport protein

Also Published As

Publication number Publication date
ES2345318T3 (en) 2010-09-21
ZA200206550B (en) 2003-12-19
PT1259606E (en) 2010-08-02
JP4861590B2 (en) 2012-01-25
FR2805266B1 (en) 2004-12-03
JP2003523193A (en) 2003-08-05
FR2805266A1 (en) 2001-08-24

Similar Documents

Publication Publication Date Title
DK1351958T3 (en) Imidazol-5-yl-2-anilinopyrimidines as agents for inhibiting cell proliferation
DK1312239T3 (en) Techniques for suppressing interference
DK1553929T3 (en) Controlled release composition.
PT1209972E (en) HERBICIDE COMPOSITION
DE60125929D1 (en) PHOTO-ACTIVE COATING COMPOSITION
AR027928A1 (en) HERBICIDE COMPOSITION
NO20023672D0 (en) Controlled Release Compositions
DK1504126T3 (en) PROCEDURE FOR REGULATING GENEPRESSION
DK1176195T3 (en) Method for controlling the activity of immunologically functional molecule
ITTO20000976A0 (en) ACARICIDE COMPOSITIONS.
DE60014105D1 (en) IMPROVED HERBICIDE COMPOSITION
NO20035245L (en) Basic Wi-Fi architecture for 802.11 networks
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
NL300242I2 (en) Omega-carboxyaryl substituted diphenylureas as raf kinase inhibitors.
DE60219382D1 (en) Improved coating composition
MA25919A1 (en) PEST CONTROL COMPOSITION.
NO20041965L (en) Deposition control composition for high deposition environment.
PT1429610E (en) HERBICIDE COMPOSITION
DK1158963T3 (en) Controlled Release Betahistine Compositions
NO20031316D0 (en) coating Compositions
DK1159871T3 (en) Stable or booth for dividing manure
ATE468751T1 (en) IMPROVED HERBICIDE COMPOSITION
NO20014586D0 (en) Resorcinol compositions
DK1390364T3 (en) Aryl-8-azabicyclo [3.2.1] octanes for the treatment of depression
DK1259606T3 (en) Compositions suitable for regulating parkin activity